scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1092371233 |
P356 | DOI | 10.1038/S41598-017-14622-3 |
P932 | PMC publication ID | 5660209 |
P698 | PubMed publication ID | 29079735 |
P50 | author | Tone F. Bathen | Q61104171 |
May-Britt Tessem | Q64706553 | ||
Finn Drabløs | Q43415197 | ||
P2093 | author name string | Anna M Bofin | |
Elise Sandsmark | |||
Helena Bertilsson | |||
Maria K Andersen | |||
Morten B Rye | |||
P2860 | cites work | Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. | Q51050747 |
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy | Q57185246 | ||
Conducting Meta-Analyses in R with the metafor Package | Q58423162 | ||
Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer | Q73937761 | ||
Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer | Q83698264 | ||
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy | Q87828465 | ||
Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling | Q22011203 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro | Q24307058 | ||
Overdiagnosis and overtreatment of prostate cancer | Q26859596 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease | Q28115466 | ||
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer | Q28251800 | ||
An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account | Q28484126 | ||
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy | Q28534277 | ||
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome | Q29616165 | ||
Integrative genomic profiling of human prostate cancer | Q29619905 | ||
Molecular sampling of prostate cancer: a dilemma for predicting disease progression | Q33541296 | ||
In silico estimates of tissue components in surgical samples based on expression profiling data | Q33642598 | ||
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients | Q33904020 | ||
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer | Q34266112 | ||
Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer | Q34625191 | ||
The Molecular Taxonomy of Primary Prostate Cancer | Q34674332 | ||
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness | Q34693066 | ||
Diagnosis of prostate cancer using differentially expressed genes in stroma | Q34763431 | ||
Secreted Frizzled-related proteins: searching for relationships and patterns | Q34811402 | ||
Molecular differences in transition zone and peripheral zone prostate tumors | Q36067907 | ||
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study | Q36106271 | ||
sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss | Q36841079 | ||
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease | Q37102953 | ||
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer | Q37520447 | ||
A novel non-canonical Wnt signature for prostate cancer aggressiveness | Q37706021 | ||
Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. | Q38287048 | ||
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System | Q38613858 | ||
SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms. | Q38749465 | ||
The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer | Q38814732 | ||
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer | Q39292672 | ||
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy | Q40369700 | ||
Gene expression analysis of prostate cancers | Q40664417 | ||
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. | Q46658469 | ||
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy | Q46843127 | ||
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples | Q47892665 | ||
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy | Q50260314 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 14276 | |
P577 | publication date | 2017-10-27 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | SFRP4 gene expression is increased in aggressive prostate cancer | |
P478 | volume | 7 |
Q92382465 | High expression of fibronectin 1 indicates poor prognosis in gastric cancer |
Q56989931 | Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates |
Q64242272 | SFRP4 is a prognostic marker and correlated with Treg cell infiltration in pancreatic ductal adenocarcinoma |
Search more.